Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke

Completed

Phase 3 Results

Main Contacts

Name Phone E-mail
Takenori Yamaguchi, MD Study Chair

Other Locations

Name City State Country Status
National Cardiovascular Center Suita Osaka Japan Unknown_status_icon